A medical desert isn't only about distance to a hospital. It's about predictability of supply: whether the syringe, the IV set, or the basic device is actually on the shelf when a patient needs it. Across the United States, the facilities furthest from the supply center are the ones that run dry first.
Why the edges get shorted first
Most medical consumables are bought reactively, on the spot market. When supply tightens, whether from a manufacturing disruption, a demand spike, or a national shortage, allocation flows to the largest, closest, highest-volume buyers. Rural hospitals, small clinics, and underserved urban facilities sit at the back of that line. The result is a system that fails predictably at its edges, exactly where care is already hardest to deliver.
Shortages aren't anomalies. They're structural
Recurring shortages of IV fluids, common injectables, and basic devices keep surprising the system, but they're not surprises. Spot-buying optimizes for the average case and breaks under stress. When the model has no forward commitment, there's no buffer, no pre-positioned inventory, and no price protection, so the shock lands on whoever has the least leverage.
The fix: make supply a commitment, not a scramble
A Digital Long-Term Agreement inverts the model. Instead of reacting, a facility commits to volume over time; in exchange, the supplier forecasts demand ahead, pre-plans shipments on a fixed calendar, locks the price, and vets every shipment. Pre-positioned, predictable supply is precisely what a medical desert lacks, and precisely what removes the "back of the line" dynamic during a shortage.
Where Bonn-Weiss Group fits
Bonn-Weiss Group is built on this model: AI-forecasted demand 52 weeks out, Digital Long-Term Agreements with locked pricing, vendor-managed inventory, and per-shipment quality vetting. The company operates today from India. The US market, including its medical deserts, is where a predictability-first supply model has the most to prove and the most to change.